Second, focus on delivery to the population of patients where the service is responding to an identified need—for example, patients in transition between services (such as the young people we studied); patients in transition between treatments (eg, a person with diabetes starting insulin), or before or after treatment (eg, liver transplant); and patients in transition in their life (eg, starting university)—and monitor impact on staff workload. This evidence concerns the gene INS and diabetes mellitus.